The QT interval, a measure of cardiac repolarization, predisposes to ventricular arrhythmias and sudden cardiac death (SCD) when prolonged or shortened. A common variant in NOS1AP is known to influence repolarization. We analyze genome-wide data from five population-based cohorts (ARIC, KORA, SardiNIA, GenNOVA and HNR) with a total of 15,842 individuals of European ancestry, to confirm the NOS1AP association and identify nine additional loci at P o 5 Â 10 À8 . Four loci map near the monogenic long-QT syndrome genes KCNQ1, KCNH2, SCN5A and KCNJ2. Two other loci include ATP1B1 and PLN, genes with established electrophysiological function, whereas three map to RNF207, near LITAF and within NDRG4-GINS3-SETD6-CNOT1, respectively, all of which have not previously been implicated in cardiac electrophysiology. These results, together with an accompanying paper from the QTGEN consortium, identify new candidate genes for ventricular arrhythmias and SCD.
The lack of serologic biomarkers to predict ventricular tachycardia, ventricular fibrillation and sudden cardiac death has made genomewide searches for common genetic variants influencing these traits extremely important 1 . Studies of the QT interval from the electrocardiogram (EKG), which captures major temporal and spatial aspects of the repolarization process, are particularly attractive as its prolongation or shortening reflects alterations of cardiac repolarization known to trigger ventricular tachycardia and ventricular fibrillation and predispose to SCD 2 . Importantly, QT interval prolongation has been associated with increased cardiovascular mortality in individuals with heart disease 3 , as well as in the general population 4 . Furthermore, mutations in genes associated with long-and short-QT syndromes (LQTS, SQTS) markedly increase the odds of SCD 5 .
Previous genetic analyses of QT interval have largely relied on family-based studies focused on rare mendelian QT syndromes. These have resulted in the identification of eleven genes in which mutations cause prolongation or shortening of the QT interval and SCD. Recently, in an initial genome-wide association study (GWAS) in the KORA community-based cohort, an association between common genetic variants in the NOS1AP (CAPON) gene and the QT interval was identified 6 . This association highlights the importance of the nitric oxide synthase pathway in myocardial function and has now been replicated in several studies [7] [8] [9] . Genetic variants at NOS1AP explain B1% of the variance in QT interval, and common genetic variants in NOS1AP are also associated with SCD in populations of European ancestry 10 .
In this study, we carried out GWAS in five population-based cohorts from Europe and the United States (ARIC 11 , SardiNIA 12 , KORA 13 , GenNOVA 14 and Heinz Nixdorf Recall (HNR) 15 ) (Supplementary Table 1 online). In all the participating studies all individuals studied and all analyses on their samples were done according to the Helsinki declarations and were approved by the local medical ethics and institutional review committees. All participants gave signed informed consent. We used preexisting genome-wide SNP data of All SNPs Excluding SNPs in NOS1AP Excluding SNPs in all associated loci Figure 1 Manhattan and quantile-quantile plots of genome-wide association analyses. Genome-wide association results were combined across all studies by inverse variance weighting. The blue dotted line marks the threshold for genome-wide significance (5 Â 10 À8 Table 3a online). The standard deviation of the adjusted QT interval meta-analyzed across all studies was ±17.8 ms.
RESULTS

Meta-analysis of GWAS studies of QT interval
Results for the consequent genome-wide analysis are summarized in Figures 1 and 2 . The genomic control factor (l) for this analysis was 1.016, indicating that unmodeled relatedness and population structure had no appreciable impact on our results 17 . The quantile-quantile plot in Figure 1 (inset) shows a clear excess of extreme P values, indicating the presence of true associations. After having identified ten main association signals across the genome (P o 5 Â 10 À8 ) we carried out a second round of genome-wide analysis after adjusting for the main signals. This round led to the identification of independent secondary signals in two of the ten loci (P o 5 Â 10 À8 ).
Replication of association in the NOS1AP locus Consistent with a previous GWAS study 6 , the strongest main association signal maps to the NOS1AP locus. There, the most significant association was at SNP rs12143842 (P ¼ 1.62 Â 10 À35 , Figs. 1 and 2b, Table 1 , and Supplementary Table 4 online). In the NOS1AP locus we identified an independent secondary signal at rs4657178 which was in low linkage disequilibrium (LD) to the main signal (r 2 ¼ 0.001 to rs12143842 in HapMap CEU, P ¼ 1.02 Â 10 À22 before and 9.98 Â 10 À13 after adjustment for main association signals, Table 2 ) supporting the notion of at least two common QT-modifying variants at that locus. The SNP rs10494366, indicating the most significant association signal in the previous report 6 , was in moderate LD with the main signal, and to a lesser degree also with the secondary signal ( Table 3) . After adjustment for the ten main association signals a significant reduction in the association with this SNP occurs, indicating that it does not represent an independent tertiary signal but rather a marker for the main signal at rs12143842. After excluding SNPs in a 1-Mb region surrounding NOS1AP, we still observed a clear excess of small P values distributed across several genetic loci (Fig. 1, inset) , indicating the presence of additional genomic loci associated with the QT interval. Overall, nine additional loci show association at P o 5 Â 10 À8 , corresponding to genomewide significance at 5% after adjustment for B1 million independent tests, the estimated multiple testing burden of HapMap SNPs in samples of European ancestry 16 .
Identification of association signals at four LQTS-related genes
Notably, four of these associations map in or near genes known to harbor both LQTS-and SQTS-causing mutations: KCNQ1 (LQT1, SQT2, 11p15.5, rs12296050, P ¼ 8.52 Â 10 À9 ), KCNH2 (LQT2, SQT1, 7q36.1, rs2968863, P ¼ 3.79 Â 10 À9 ), KCNJ2 (LQT7, SQT3, 17q24.3, rs17779747, P ¼ 3.36 Â 10 À8 ) and SCN5A (LQT3, Brugada syndrome, 3p22.2, rs11129795 with P ¼ 3.67 Â 10 À8 ). SCN5A encodes a sodium channel, and, in previous studies, the nonsynonymous variant S1103Y with allele frequency 8% only in individuals of African ancestry has been associated with increased risk of arrhythmias 18 . The three other genes encode potassium channel a-subunits in the cardiomyocyte plasma membrane.
Previous candidate gene analyses provided evidence of association between common variants and QT interval for three of these loci: KCNQ1, KCNH2 and SCN5A. We investigated the previously identified This table lists the most significantly associated SNP at the ten identified loci. In each locus, at least one marker exceeds the genome-wide significant threshold of 5 Â 10 À8 . Beta coefficient and standard error are relative to the regression model when using QT residuals as dependent variable. Meta-analysis with data from the QTGEN consortium 34 supports the evidence of association at each locus. 'Method' indicates whether a SNP has been directly genotyped on one of the array platforms (GT) or whether its genotypes have been imputed in all of the samples (I). A more complete list including at least one genotyped SNP from each of the ten loci can be found in Supplementary Table 4 . RSQR (sometimes also termed OEvar) denotes the average of the ratio of the observed variance of imputed allele counts to their expectation based on estimated allele frequencies weighted for all samples from QTSCD, which indicates deviation from Hardy-Weinberg equilibrium and quality of imputation. SNPs data were only included if RSQR exceeded a value of 0.3 in the respective study. N(eff) denotes our estimate of the effective number of analyzed individuals in QTGEN.
a For SNP rs846111 in RNF207 SardiNIA and Kora F3, results were not used because of RSQR o 0.3.
variants with respect to our data on the basis of their surrounding LD patterns and effect sizes before and after adjustment for the main signals ( Table 3 and Supplementary Fig. 1 online) . The nonsynonymous coding KCNH2 variant K897T (rs1805123) [19] [20] [21] , the variant in intron 1 of KCNQ1 (rs757092) 20 and the noncoding SCN5A variant D1819D (rs1805126) 22 all seem to be in LD with the main association signals we detected. After adjustment for the main signals, with which they were in moderate to high LD, these SNPs were no longer significantly associated. In contrast, the signal at the SCN5A variant H558R (rs1805124) 22 did not reach genome-wide significance in our data (P ¼ 4.06 Â 10 À3 ) but remained almost unchanged after adjustment, suggesting a small but independent association signal. Additionally, the previously published secondary association signals in KCNH2 show independent but slightly less than genome-wide significant signals in our data: rs3815459 (ref. Table 3) . Both seem to be in LD with the strongest secondary signal we identified in KCNH2 at rs3778873 bordering genome-wide significance (P ¼ 5.07 Â 10 À8 before and P ¼ 7.90 Â 10 À5 after adjustment for main signals) (Supplementary Table 5 online). These results emphasize that in many loci we are likely to identify genes with an allelic series comprising both common variants influencing QT interval with modest effects (B3-6 ms per locus in this study) in healthy volunteers as well as rare variants with a more marked effect (4100 ms) in individuals with a genetic syndrome 23 .
In the 17q24.3 region the strongest association signal was missed in previous candidate gene studies probably because the associated signal at SNP rs17779747 maps B300 kb away from the KCNJ2 gene. Although the LD block it resides on extends toward the gene, SNP rs17779747 is not in high LD with any common variant within the KCNJ2 coding sequence, the strongest being to the synonymous coding rs173135 (L382L, r 2 ¼ 0.014). KCNJ2 remains the best prior candidate in the region as mutations in it are known to cause Andersen syndrome (MIM170390), a condition characterized by periodic paralysis, dysmorphic features and cardiac ventricular arrhythmias triggered by repolarization disturbances. Alternatively, other genes from the region, including the nearby paralog KCNJ16, may have a role 24 .
Association with two myocardial ATPase-related genes We identified two new loci with genes encoding proteins with wellestablished myocardial electrophysiological functions: in chromosome 1q24.2 the strongest signal was within ATP1B1 (Na + /K + ATPase beta subunit 1, rs10919071, P ¼ 2.18 Â 10 À12 , Fig. 2c ). ATP1B1 encodes a transmembrane protein that has a crucial role in the maintenance of Na + and K + gradients across membranes, thus regulating electrical excitability of muscles, and may also be involved in the regulation of blood pressure 25 . These data make ATP1B1 a strong functional candidate, although NME7, BLZF1, C1orf114 and SLC19A2 cannot be excluded without functional validation.
In chromosome 6q22.31 a broad association signal covers PLN (phospholamban), SLC35F1 and C6orf204, with the strongest signal at the intergenic SNP rs11970286 (P ¼ 1.96 Â 10 À16 , Fig. 2e) . PLN is the strongest regional candidate, as it is a regulator of the sarcoplasmic reticulum Ca 2+ ATPase (encoded by ATP2A2, also known as SERCA2) responsible for diastolic lowering of the cytoplasmic Ca 2+ concentration. Mutations in this gene have previously been associated with inherited cardiomyopathies and congestive heart failure 26 . Neither SLC35F1 nor C6orf204 has previously been shown to have a functional role in the myocardium. In the 6q22.31 region we identified an independent second variant (rs12210810, intergenic, P ¼ 3.24 Â 10 À13 before and P ¼ 4.50 Â 10 À8 after adjustment for main signals). The low LD to the main signal (r 2 = 0.067) and the fact that the rare allele at this second signal was associated with shorter QT intervals strengthen the assumption of two independent causal variants in or near PLN. At each of these two loci, there were no additional compelling biological candidates that we could identify.
Association signals in three previously unrecognized loci At the remaining three loci discovered, there was no obvious biological candidate. One of these loci in chromosome 1p36.31 overlaps LITAF (rs8049607, P ¼ 2.90 Â 10 À8 , Fig. 2h ), which encodes a DNA-binding protein thought to have a role in the regulation of TNFA expression. Mutations in this gene have previously been implicated in CharcotMarie-Tooth type 1C neuropathy and are sometimes associated with reduced nerve conduction velocity 27 . Another candidate gene in the region is TXNDC11, which encodes thioredoxin domain-containing protein 11 and harbors a nonsynonymous SNP in weak LD with the leading variant (V756L, rs3190321, r 2 ¼ 0.022), as well as SNN, encoding stannin (rs8191288, r 2 ¼ 0.022). A second newly identified locus was in chromosome 1p36.31, with a nonsynonymous coding SNP in RNF207 as the main signal (G603A, rs846111, P ¼ 3.56 Â 10 À9 , Fig. 2a) . Its best proxy, rs709209, is another nonsynonymous SNP in the same gene (N573S, r 2 ¼ 0.673). RNF207 encodes a RING-type zinc-finger protein of unknown function. Other regional Table 3 for a more detailed analysis of previously published QT associations from candidate genes. LD data are from HapMap.
candidate genes are GPR153 (rs4908542, intronic, r 2 ¼ 0.445), CHD5 (rs12754299, r 2 ¼ 0.021), ICMT (rs846108, r 2 ¼ 0.020), HES2 (rs932402, r 2 ¼ 0.018) and the gene for the shaker-related potassium channel KCNAB2 (rs2294934, r 2 ¼ 0.028). None of the SNPs in the neighboring genes were coding and none of the genes have been previously implicated in myocardial pathology. The third identified locus maps to chromosome 16q21, the strongest signal being an intronic SNP within the CNOT1 gene (rs7188697, P ¼ 1.25 Â 10 À12 , Fig. 2i) , encoding a subunit of the CCR4-NOT transcription complex. This locus is highly conserved and syntenic in many vertebrates and contains other potentially causal genes such as SETD6, encoding SET domain-containing protein 6 (rs37036, r 2 ¼ 0.920), NDRG4, encoding vascular smooth muscle cell-associated protein 8 (SMAP-8) (rs40186, r 2 ¼ 0.468), and GINS3, encoding GINS complex subunit 3 (rs8054945, r 2 ¼ 0.041). A recent genetic screen in zebrafish mutants of resistance and sensitization to dofetilide, a drug causing atrioventricular blocks, uncovered a GINS3 mutation that modifies cardiac repolarization (personal communication, D. Milan, Massachusetts General Hospital and Harvard Medical School). NDRG4, a gene known to be expressed in the heart during zebrafish development that regulates proliferation and growth of cardiomyocytes 28 , is also a plausible candidate. Human NDRG4 has three alternative promoters, all of them containing consensus binding sequences for the Tbx5 transcription factor 29 , which is known to operate in conjunction with Nkx2.5 in human heart development 30 . Additionally, a combined effect of several genes may exist given the high degree of conserved synteny in that locus. For all the loci we identified, but particularly for these last three, more experimental evidence will be required to identify likely functional mechanisms. This could include the sequencing of genes in individuals with unexplained long-QT syndrome and functional screens in model organisms.
Investigation of explained variance and sex-specific effects
The nine newly identified main association signals identified here increase the proportion of explained variance in heart rate-, sex-and age-adjusted QT interval from 1.0% by the NOS1AP SNP rs12143842 signal alone to 3.3% in a meta-analysis across all studies; a more comprehensive analysis of all variation at these loci, including secondary signals, is likely to increase this quantity further. In addition, there are likely rarer variants at each of these genes that modulate QT intervals to a greater extent but have been missed in our screen for common variants, as has been observed for highdensity-lipoprotein cholesterol levels 31 . Results after adjustment for the ten main SNPs: 0.3842 0.2481 1.22e-01
We compared association results identified in QTSCD to previously published association signals. The previously identified signal in NOS1AP (rs10494366) (ref. 6 ) is in weak to moderate LD to both the first (rs12143842, r 2 ¼ 0.11) as well as the secondary association signal identified in our study (rs4657178, r 2 ¼ 0.04). Data after adjustment (gray line) indicate its contribution to be almost entirely accounted for by rs12143842. In SCN5A, the synonymous SNP D1819D (rs1805126, ref. 22 ) drops in signal by adjustment, indicating that it is accounted for by the main SCN5A hit. In contrast, the nonsynonymous SCN5A SNP H558R has a signal that is not genome-wide significant but holds up after adjustment. H558R may therefore be a weak but independent signal in SCN5A. The signal identified in KCNH2 (rs2968863) is in LD to the previously identified nonsynonymous SNP KCNH2-K897T (rs1803123, refs. 19-21) and accounts for its association signal. Two intronic SNPs have previously been published to represent second independent signals in KCNH2: rs3815459 (ref. 20) (tagged by rs3778873) and rs3807375 (ref. 21 ). Both are in LD (r 2 ¼ 0.45*) and retain most of their association signal after adjusting, thus supporting the existence of a second signal in KCNH2. In addition, the genome-wide analysis of SNPs after adjustment for main signals also identifies rs3778873 as a potential second hit (P ¼ 7.9 Â 10 -5 ) (Supplementary Table 5 Variation in demographic factors such as age and sex also contributes to the QT interval phenotype 32 . We carried out association analysis for males and females separately, and for younger and older subgroups of individuals (stratified by age r50 y). As shown in Table 4 , the main signal at NOS1AP shows a stronger effect in females, supporting a recently published study that demonstrated a sex-specific effect for SNP rs10494366 (refs. 9,33) . In addition, we observed data supporting the possibility of age-specific effects at RNF207 and PLN. In RNF207 the QT-prolonging effect of the rare C allele of rs846111 is 1.277 ms larger in young individuals (P ¼ 0.014), whereas in PLN the QT-shortening effect of the rare C allele of rs12210810 is 1.809 ms larger in older individuals (P ¼ 0.036). We replicated the previously published sex-specific effect at NOS1AP; no other age-or sex-specific effects remained significant after adjustment for the number of performed tests.
Comparison of results with an independently conducted GWAS study Finally, our analyses should be compared with the results of an independent yet similar GWAS by the QTGEN consortium 34 that adds further confidence in these results. All the loci that reach P o 5 Â 10 À8 in our screen also show evidence for association in their study of 13,685 individuals (each with P o 1 Â 10 À4 ). Furthermore, our data provides evidence for association with the QT interval at chromosome 17q12 near the genes LIG3 and RFFL (rs2074518, P ¼ 3.03 Â 10 À6 ), a locus that exceeded the genome-wide significance threshold in the QTGEN consortium. Owing to reduced genotyping coverage of the KCEN1 locus as compared to QTGEN, our data do not support the association with the nonsynonymous D85N variant in KCNE1 (refs. 20,22,34-36) .
Evaluation of a QT score
To assess the cumulative effect of the ten main QT-associated SNPs, we summed up the number of QT interval-prolonging alleles for each participant in the studies of unrelated individuals (N ¼ 10,563) (Supplementary Methods). Overall, we observed a 1.53 ± 0.08 ms (P ¼ 1.79 Â 10 À88 ) increase in the mean QT interval for each additional QT-prolonging allele, with a difference of 18.1 ms between individuals with a QT score of r6 or Z16 (Fig. 3) . The 58% of individuals with a score of Z11 had an OR of 1.49 for prolonged QT using clinical thresholds (males Z440 ms, females Z450 ms) when compared with the 42% of individuals with a score of r10 (95% CI ¼ 1.27-1.76, P ¼ 1.54 Â 10 À6 ). Further at the extremes, the B8% of individuals with a score of Z14 had an OR of 2.52 for prolonged QT when compared to the B10% individuals with a score r8 (95% CI ¼ 1.74-3.66, P ¼ 4.83 Â 10 À7 ). This table summarizes the combined association results for sex-and age-specific effects. Young and old subgroups were defined as age r50 y and age 450 y. None of the effects was significant after adjustment for multiple testing requiring P o 0.002.
DISCUSSION
Our results illustrate the power of GWAS to identify common variants both at loci previously unsuspected of involvement in cardiovascular function as well as at loci with a documented role in the regulation of QT interval. Although the statistical evidence of these associations is compelling mostly owing to the size of current GWAS, we are aware of limitations of this approach. As population stratification may confound our association findings, we have calculated a genome-wide Fst statistic between populations 37 . This indicates an overall Fst statistic of 0.004 between all cohorts, comparatively minor relative to the value of 0.12 obtained by the International HapMap Project when comparing Europeans, Africans and Asians (Supplementary Table 6 online). We report cohort-specific results in Supplementary Table 7 online. Also we did not account for some known covariates of QT interval, as these either did not contribute significantly to the model fit (Supplementary Table 3b ) or were not uniformly available across studies and the increase of explained variance of QT interval was small at the population level (such as for example, for underlying cardiac pathologies, serum potassium levels and medication use) (Supplementary Table 3c ). We may potentially have missed some association signals especially in the presence of interaction. As most complex genetic associations identified today perform well in log linear models 38 and as the accompanying study 34 did not identify any loci that our study would dismiss, we do not consider this limitation a major one. A post hoc analysis of the ten main association signals identified in a model fitting additional covariates indicated no major improvement in model fit (Supplementary Table 8 online): six out of the ten loci slightly gained in significance level attained, whereas four loci decreased. Other limitations include the overestimation of effect sizes in initial discoveries due to the 'winners curse' phenomenon and the inability of the association approach to identify underlying genes or mechanisms in the regions of association signals.
The identification of causal genes and mechanisms at each of the loci remains a major task. This may be performed by functional experiments, but genetic studies are integral to scrutinize loci for causal mutations and establish pathways that regulate myocardial function. Promising genetic methods include SNP fine mapping at each locus at a resolution higher than that of the HapMap, and resequencing the target locus in individuals from the extremes of the QT interval distribution and in individuals diagnosed with long-QT syndrome in order to identify additional common as well as rare variants that may reveal the causal genes. The approach of establishing an allelic series at a given locus including both common and rare variants seems particularly promising. Four of ten loci we identified by association do overlap with genes known to harbor mutations in LQTS and SQTS. Loci showing allelic series have also been identified in genome-wide association studies of lipid levels 39 , height 40 and uric acid 41 . In the future, it may be worthwhile to include all the loci identified here in sequencing efforts in cases of long-and short-QT syndromes and in subjects where these syndromes are induced after exposure to specific medications. More immediately, our results point to a specific set of loci that are associated with QT interval and provide further targets for molecular studies of susceptibility to QT-triggered ventricular arrhythmias, sudden cardiac death and cardiovascular function in general. Figure 3 Combined effect of the QT interval-prolonging alleles in the studies of unrelated individuals. Individuals were classified by counting their number of QT-prolonging alleles in all ten identified markers (max score 20). Dosages for the QT-prolonging allele as calculated by MACH1 were added and then rounded to the nearest integer. Gray bars indicate the number of individuals in each score class, blue dots indicate the mean QT interval for each class, and the black line is the linear regression though these points.
